NCT01605812

Brief Summary

In this study, the investigators examined the capsule-IOL interaction including anterior and posterior capsule adhesion, contact between posterior capsule and the posterior edge of intraocular lense (IOL), configuration of capsular bend and the incidence of posterior capsular opacity (PCO) between high myopia eyes and emmetropia eyes.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2011

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2011

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

May 11, 2012

Completed
14 days until next milestone

First Posted

Study publicly available on registry

May 25, 2012

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2016

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

January 9, 2015

Status Verified

January 1, 2015

Enrollment Period

5.4 years

First QC Date

May 11, 2012

Last Update Submit

January 7, 2015

Conditions

Keywords

IOL;capsule;PCO;OCT

Outcome Measures

Primary Outcomes (1)

  • Evaluate Capsular Apposition to Intraocular Lens in high myopia eyes and emmetropia eyes with different types of IOL

    4hour, 1day, 7day, 14day, 28day, 3month, 6month, 12month

Study Arms (2)

high myopia

high myopia (axial length\>26mm)

emmetropia

emmetropia (22\<axial length\<25mm) as control group.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

This prospective study consisted consecutive patients with high axial myopia (myopia group) and age-matched patients with normal axial length (control group). All eyes underwent uncomplicated phacoemulsification with a single-piece IOL (AcrySof, Alcon) implantation for cataract treatment.

You may qualify if:

  • Eyes with an AL of 26.00mm or more were recruited to the high myopia group.
  • Eyes with an AL of 22.00 to 25.00 mm were recruited to the emmetropia group.

You may not qualify if:

  • patients who could not be available for follow-up.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wenzhou Medical University

Wenzhou, Zhejiang, 325027, China

RECRUITING

Related Publications (1)

  • Tao A, Lu P, Li J, Shao Y, Wang J, Shen M, Zhao Y, Lu F. High resolution OCT quantitative analysis of the space between the IOL and the posterior capsule during the early cataract postoperative period. Invest Ophthalmol Vis Sci. 2013 Oct 25;54(10):6991-7. doi: 10.1167/iovs.13-12849.

MeSH Terms

Conditions

Capsule OpacificationTissue Adhesions

Condition Hierarchy (Ancestors)

CataractLens DiseasesEye DiseasesCicatrixFibrosisPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • yune zhao, MS

    Wenzhou Medical University

    STUDY CHAIR

Central Study Contacts

yinying zhao, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
doctor of ophthalmology, Principal Investigator, Clinical Professor

Study Record Dates

First Submitted

May 11, 2012

First Posted

May 25, 2012

Study Start

April 1, 2011

Primary Completion

September 1, 2016

Study Completion

December 1, 2016

Last Updated

January 9, 2015

Record last verified: 2015-01

Locations